Association between MMP-3 and MMP-9 polymorphisms and coronary artery disease

Beton,Osman; Arslan,Serdal; Acar,Burak; Ozbilum,Nil; Berkan,Ocal

doi:10.3892/br.2016.782

Association between MMP-3 and MMP-9 polymorphisms and coronary artery disease

Authors:
- Osman Beton
- Serdal Arslan
- Burak Acar
- Nil Ozbilum
- Ocal Berkan
View Affiliations

Affiliations: Department of Cardiology, Heart Center, Cumhuriyet University, Sivas 58140, Turkey, Department of Medical Biology, Cumhuriyet University, Sivas 58140, Turkey, Department of Cardiology, Turkiye Yuksek Ihtisas Research and Training Hospital, Ankara 06100, Turkey, Molecular Biology and Genetics, Heart Center, Cumhuriyet University, Sivas 58140, Turkey, Cardiovascular Surgery, Heart Center, Cumhuriyet University, Sivas 58140, Turkey
Published online on: October 18, 2016 https://doi.org/10.3892/br.2016.782
Pages: 709-714

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Matrix metalloproteinase (MMP)-3 and MMP-9 polymorphisms are characterized by plaque stability in coronary arteries. The aim of the current study was to investigate the 5A/6A polymorphism in the MMP‑3 gene and C/T polymorphism in the MMP‑9 gene in patients with coronary artery disease (CAD). The study population consisted of 400 patients who underwent coronary angiography. There were two groups consisting of 200 consecutive patients with CAD, presenting with stable angina pectoris, and 200 consecutive patients exhibiting normal coronary arteries. Two single nucleotide polymorphisms in the MMP gene, MMP‑3 and MMP‑9, were detected using a polymerase chain reaction‑restriction fragment length polymorphism assay. Mean age, gender distribution, smoking status, presence of diabetes mellitus and hypercholesterolemia were identified to be similar between the groups. One hundred and twenty seven (63.5%) patients had hypertension in the CAD group, whereas only 55 (27.5%) patients had hypertension in the control group (P<0.001). No significant difference in frequency of alleles and genotypes of MMP‑9 C→T between the CAD and control groups was identified. The 5A allele frequency of MMP‑3 in the CAD group was significantly higher when compared with the control group (P<0.001; odds ratio=2.18). The genotype frequency of MMP‑3 5A/5A in the CAD group was significantly higher when compared with the controls (P=0.005). When compared with the homozygous wild-type (6A/6A) genotype of the MMP‑3 gene, the cumulative frequency of heterozygote and homozygote genotypes of the MMP‑3 gene was significantly higher in the CAD compared with the control group (P<0.001). Thus, the present study demonstrated that the 5A/5A and 6A/5A+5A/5A genotypes of the MMP‑3 gene were associated with an increased risk of CAD.

View Figures

View References

1	Abilleira S, Bevan S and Markus HS: The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet. 43:897–901. 2006. View Article : Google Scholar : PubMed/NCBI
2	Chen QJ, Lu L, Peng WH, Hu J, Yan XX, Wang LJ, Zhang Q, Zhang RY and Shen WF: Polymorphisms of MMP-3 and TIMP-4 genes affect angiographic coronary plaque progression in non-diabetic and type 2 diabetic patients. Clin Chim Acta. 405:97–103. 2009. View Article : Google Scholar : PubMed/NCBI
3	Ye S, Gale CR and Martyn CN: Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur Heart J. 24:1668–1671. 2003. View Article : Google Scholar : PubMed/NCBI
4	Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, et al: Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 99:1788–1794. 1999. View Article : Google Scholar : PubMed/NCBI
5	Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P and Ye S: Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol. 41:2130–2137. 2003. View Article : Google Scholar : PubMed/NCBI
6	Rauramaa R, Väisänen SB, Luong LA, Schmidt-Trücksäss A, Penttilä IM, Bouchard C, Töyry J and Humphries SE: Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol. 20:2657–2662. 2000. View Article : Google Scholar : PubMed/NCBI
7	Liu PY, Li YH, Chan SH, Lin LJ, Wu HL, Shi GY and Chen JH: Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. Am J Cardiol. 98:1012–1017. 2006. View Article : Google Scholar : PubMed/NCBI
8	Johnson C and Galis ZS: Matrix metalloproteinase-2 and −9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol. 24:54–60. 2004. View Article : Google Scholar : PubMed/NCBI
9	Sambrook J and Russell DW: Purification of nucleic acids by extraction with phenol: chloroform. CSH Protoc. 2006(pii): pdb.prot4455. 2006.
10	Xie X and Ott J: Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet. 53:1107–1113. 1993.PubMed/NCBI
11	Hoppmann P, Koch W, Schömig A and Kastrati A: The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions. Eur Heart J. 25:335–341. 2004. View Article : Google Scholar : PubMed/NCBI
12	Koch W, de Waha A, Hoppmann P, Schömig A and Kastrati A: Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: Case-control study and a meta-analysis. Atherosclerosis. 208:171–176. 2010. View Article : Google Scholar : PubMed/NCBI
13	Ye S, Watts GF, Mandalia S, Humphries SE and Henney AM: Preliminary report: Genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J. 73:209–215. 1995. View Article : Google Scholar : PubMed/NCBI
14	Humphries S, Bauters C, Meirhaeghe A, Luong L, Bertrand M and Amouyel P: The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J. 23:721–725. 2002. View Article : Google Scholar : PubMed/NCBI
15	de Maat MP, Jukema JW, Ye S, Zwinderman AH, Moghaddam PH, Beekman M, Kastelein JJ, van Boven AJ, Bruschke AV, Humphries SE, et al: Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol. 83:852–856. 1999. View Article : Google Scholar : PubMed/NCBI
16	Humphries SE, Luong LA, Talmud PJ, Frick MH, Kesäniemi YA, Pasternack A, Taskinen MR and Syvänne M: The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis. 139:49–56. 1998. View Article : Google Scholar : PubMed/NCBI
17	Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, Murohara T and Yokota M: Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol. 42:1429–1437. 2003. View Article : Google Scholar : PubMed/NCBI
18	Schwarz A, Haberbosch W, Tillmanns H and Gardemann A: The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease. Dis Markers. 18:121–128. 2002. View Article : Google Scholar : PubMed/NCBI
19	Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F and Tiret L: AtheroGene Investigators: Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 107:1579–1585. 2003. View Article : Google Scholar : PubMed/NCBI
20	Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, et al: Haplotype tagging for the identification of common disease genes. Nat Genet. 29:233–237. 2001. View Article : Google Scholar : PubMed/NCBI